# Biological Changes in Fibrovascular Membranes of Patients With Proliferative Diabetic Retinopathy Following Faricimab Injection

> **NCT07144865** · NA · COMPLETED · sponsor: **Bojie Hu** · enrollment: 8 (actual)

## Conditions studied

- Proliferative Diabetic Retinopathy

## Interventions

- **DRUG:** conbercept ophthalmic injection （0.5mg）
- **DRUG:** Faricimab

## Key facts

- **NCT ID:** NCT07144865
- **Lead sponsor:** Bojie Hu
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-01
- **Primary completion:** 2025-04-01
- **Final completion:** 2025-04-01
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2025-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07144865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07144865, "Biological Changes in Fibrovascular Membranes of Patients With Proliferative Diabetic Retinopathy Following Faricimab Injection". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07144865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*